Our aim was to evaluate the impact of intravitreal ranibizumab pretreatment on the outcome of vitrectomy surgery for advanced proliferative diabetic retinopathy. The objective was to determine the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results